Two Sigma Advisers
MRTX

Two Sigma Advisers’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Two Sigma Advisers’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-40,600
Closed -$2.73M – 2779
2022
Q2 		$2.73M Buy
40,600
+26,600
+190% +$1.69M 0.01% 1056
2022
Q1 		$1.15M Sell
14,000
-12,300
-47% -$1.26M ﹤0.01% 1566
2021
Q4 		$3.86M Sell
26,300
-14,400
-35% -$2.24M 0.01% 888
2021
Q3 		$7.2M Sell
40,700
-28,300
-41% -$4.55M 0.02% 626
2021
Q2 		$11.1M Sell
69,000
-63,600
-48% -$10.2M 0.03% 526
2021
Q1 		$22.7M Sell
132,600
-2,000
-1% -$396K 0.06% 332
2020
Q4 		$29.6M Buy
134,600
+49,000
+57% +$10.6M 0.08% 255
2020
Q3 		$14.2M Sell
85,600
-32,200
-27% -$4.41M 0.04% 422
2020
Q2 		$13.4M Buy
117,800
+8,300
+8% +$805K 0.04% 444
2020
Q1 		$8.42M Sell
109,500
-80,900
-42% -$7.26M 0.03% 539
2019
Q4 		$24.5M Buy
190,400
+2,800
+1% +$270K 0.06% 330
2019
Q3 		$14.6M Buy
187,600
+20,700
+12% +$1.94M 0.04% 450
2019
Q2 		$17.2M Buy
166,900
+60,800
+57% +$4.73M 0.04% 444
2019
Q1 		$7.78M Buy
106,100
+18,500
+21% +$1.26M 0.02% 686
2018
Q4 		$3.72M Buy
87,600
+7,000
+9% +$279K 0.01% 912
2018
Q3 		$3.8M Buy
80,600
+54,600
+210% +$3.04M 0.01% 932
2018
Q2 		$1.28M Buy
+26,000
New +$982K ﹤0.01% 1502

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Two Sigma Advisers's MRTX Position: Q3 2022 in Review

Two Sigma Advisers sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2022, closing a stake of 40,600 shares — an estimated $2.73M sold.

Two Sigma Advisers first reported a position in MRTX in Q2 2018 and held it in 17 quarters. The position peaked at $29.6M in Q4 2020. 243 funds tracked by Wall St. Rank hold MRTX as of Q3 2022.

  • Two Sigma Advisers reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 40,600 Mirati Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2.73M.
  • Two Sigma Advisers first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2018 and held it in 17 quarters.
  • Two Sigma Advisers's Mirati Therapeutics, Inc. Common Stock position peaked at $29.6M in Q4 2020.
  • 243 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.